Skip to main content

Table 3 Health-related quality-of-life (QoL) values

From: Insulin glargine compared to neutral protamine Hagedorn (NPH) insulin in patients with type-2 diabetes uncontrolled with oral anti-diabetic agents alone in Hong Kong: a cost-effectiveness analysis

Utility or disutility Mean References
Uncomplicated type 2 diabetes 0.8140 [29]
Myocardial infarction 0.7360 [29]
Disutility post-myocardial infarction event − 0.1290 [29]
Angina 0.6828 [29]
Congestive heart failure 0.6330 [29]
Stroke 0.5450 [29]
Disutility post-stroke event − 0.2610 [29]
Peripheral vascular disease 0.5700 [30]
Microalbuminuria 0.8140 [29]
Gross proteinuria 0.8140 [29]
Haemodialysis 0.6040 [31]
Peritoneal dialysis 0.6128 [31]
Renal transplant 0.7500 [30]
Background diabetic retinopathy 0.7900 [32]
Proliferative diabetic retinopathy 0.7900 [32]
Macular oedema 0.7900 [32]
Severe vision loss 0.6700 [33]
Cataracts 0.6280 [34]
Diabetic neuropathy 0.6300 [33]
Healed ulcer (no data; assumed same as uncomplicated T2DM) 0.8140 [29]
Active ulcer 0.7500 [35]
Lower limb amputation 0.4028 [29]
Disutility post-amputation − 0.5380 [29]
Disutility for daytime non-severe hypoglycaemic event − 0.0050 [36]
Disutility for nocturnal non-severe hypoglycaemic event − 0.0070 [36]
Disutility for daytime severe hypoglycaemic event not requiring medical assistance − 0.0263 [37]
Disutility for nocturnal severe hypoglycaemic event not requiring medical assistance − 0.0263 [37]
Disutility for daytime severe hypoglycaemic event requiring medical assistance − 0.0550 [36]
Disutility for nocturnal severe hypoglycaemic event requiring medical assistance − 0.0570 [36]